期刊文献+

API-2靶向抑制PI3K/Akt信号通路干预胃癌细胞生长的研究 被引量:1

Effects of Selective Inhibition by API-2 on the Growth of Gastric Cancer Cells
下载PDF
导出
摘要 目的研究蛋白激酶B抑制剂-2(API-2)靶向抑制PI3K/Akt信号通路中Akt位点,从而对胃癌细胞生长的影响。方法使用API-2处理人胃癌细胞株SGC7901。MTT法检测0,2,4,6,8μmol/LAPI-2作用不同时间对细胞增殖的影响;荧光染料AO/EB染色观察不同浓度API-2作用24h后细胞凋亡情况;流式细胞仪检测细胞周期变化;Western blot法检测p-AKT蛋白以及下游蛋白NF-κB表达情况。结果API-2可抑制SGC7901细胞的增殖,并呈浓度和时间依赖性;不同浓度API-2作用24h后,对细胞的部分周期有明显的影响,也可直接导致肿瘤细胞凋亡、坏死,并且p-AKT蛋白及下游蛋白NF-κB表达均减少。结论API-2有效地抑制PI3K/Akt信号通路中Akt位点,影响SGC7901细胞的周期,减少NF-κB的表达,具有增殖抑制及诱导凋亡作用。 Objective To study the effect of the inhibition of Akt by API-2 in PI3K/Akt signaling pathway on the growth of gastric cancer cells. Methods SGC7901 cells were treated with API-2. The effect of API-2 (0,2,4,6,8 μmol/L) on their proliferation was observed with MTT assay. Cell apoptosis after treated with API-2 for 24 h was observed by AO/EB double staining for fluorescence microscopy. Cell cycle was analyzed by flow cytometry (FCM). The expression of p-AKT and NF-κB was detected by Western blot. Results API-2 (0,2,4,6,8 μmol/L) significantly inhibited the proliferation of SGC7901 cells in dose-and time-dependent manner. When treated with different densities of API-2 for 24 h, parts of the cell cycle of SGC7901 cells were obviously blocked. Apoptosis and necrosis of the tumor ceils were increased while p-AKT and NF-κB expression was decreased. Conclusion API-2 can inhibit proliferation and induce apoptosis of SGC7901 cells by effectively inhibiting Akt in PI3K/Akt signaling pathway, affecting cell cycle distributions of the cells, and greatly reducing the expression of NF-κB.
出处 《福建医科大学学报》 2009年第5期373-376,共4页 Journal of Fujian Medical University
基金 福建省教育厅B类科技项目(JS07009)
关键词 胃肿瘤 蛋白酶抑制药 1-磷脂酰肌醇3-激酶 蛋白质丝氨酸苏氨酸激酶 NF-κB 信号传导 细胞凋亡 肿瘤细胞 培养的 stomach neoplasms protease inhibitors 1-phosphatidylinositol 3-kinase protein- serine-threonine kinases NF-kappa B signal transduction apoptosis tumor cells, cultured
  • 相关文献

参考文献11

  • 1Loercher A, Lee T L,Richer J L, et a l. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma [J ]. CancerRes, 2004,64(18) :6511-6523.
  • 2Yu H G,Yu L L,Yang Y, et al. Increased expression of Re IA/nuclear factor-kappa B protein correlates with coloreetal tumorigenesis[J]. Oncology, 2003,65 (1) : 37-45.
  • 3Yang L,Dan H C,Sun M, et al. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt[J]. Cancer Research , 2004,64(7):4394-4399.
  • 4Levine D A,Bogomolniy F,Yee C J, et al. Frequent mutation of the PIK3CA gene in ovarian and breast cancer[J]. Clin Cancer Res, 2005,11 (8) : 2875-2878.
  • 5Hartmann W,Digon-Sontgerath B, Koch A, et al. Phosphatidylinositol 3'-kinase/AKT signaling is activated in medulloblastoma cell proliferation and is associated with reduced expressionof PTEN[J]. Clin Cancer Res, 2006, 12 (10):3019-3027.
  • 6Samules Y,Wang Z,Bardelli A, et al. High frequency of mutations of the PIK3CA gene in human cancer[-J]. Science, 2004,304(5670) :554.
  • 7Nicholson K M,Anderson N G. The protein kinase B/Akt signaling pathway in human maliganancy[J]. Cell Signal, 2002,14(5):381-395.
  • 8Pychahou P G,Jackson L N,Silva S R, et al. Targeted molecular therapy of the PI3K pathway therapeutic significance of PI3K subunit targeting in colorectal carcinoma[J]. Ann Surg, 2006,243(6):833-844.
  • 9Song G,Ouyang G,Bao S. The activation of Akt/PKB signaling pathway and cell survival[J]. J Cell Mol Med, 2005,9 (1) :59-71.
  • 10Vandermoere F,EI Yazidi-Belkoura I, Adriaenssens E, et al.The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-kB activation induced via interaction between Akt and IgB kinase-βin breast cancer cells[J]. Oncogene, 2005,24(35) :5482-5491.

同被引文献13

  • 1Pene F, Claessens YE, Muller O, et al. Role of the phos- phatidylinositol 3 - kinase/Akt and mTOR/P70S6 - kinase pathways in the proliferation and apoptosis in multiple mye-loma [J]. Oncogene, 2002,21 ( 43 ) :6587 - 6597.
  • 2Hill MM, Hemmings BA. Inhibition of protein kinase B/ Akt : implications for cancer therapy [ J ]. Pharmacol Ther, 2002,93 ( 2 - 3 ) :243 - 251.
  • 3Paweletz CP, Charboneau L, Bichsel VE, et al. Reverse phase protein microarrays which capture disease progres- sion show activation of pro - survival pathways at the canc- er invasion front [ J ]. Oncogene, 2001,20 ( 16 ) : 1981 - 1989.
  • 4Wu C, Huang J. Phosphatidylinositol 3 - kinase - Akt - mammalian target of rapamycin pathway is essential for neu- roendoerine differentiation of prostate cancer [ J ]. J Biol Chem,2007,282(6) :3571 - 3583.
  • 5Kandel ES, Skeen J, Majewski N, et al. Activation of Akt/ protein kinase B overcomes a G2/M cell cyele checkpoint induced by DNA damage [ J ]. Mol Cell Biol, 2002, 22 (22) :7831 -7841.
  • 6Xin M, Deng X. Nicotine inactivation of the proapoptotic function of Bax through phosphorylation [ J ]. J Biol Chem, 2005,280( 11 ) :10781 - 10789.
  • 7Henshall DC, Araki T, Schindler CK, et al. Activation of Bcl -2 - associated death protein and counter - response of Akt within cell populations during seizure - induced neuronal death [ J ]. J Neurosci, 2002,22 ( 19 ) : 8458 - 8465.
  • 8Wang XT, Pei DS, Xu J. et al. Opposing effects of Bad phosphorylation at two distinct sites by Aktl and JNK1/2 on ischemic brain injury [ J ]. Cell Signal, 2007,19 ( 9 ) : 1844 - 1856.
  • 9刘勇,戴艳枝,路名芝.Akt/PKB异常与消化系统肿瘤的研究进展[J].临床与实验病理学杂志,2008,24(4):482-484. 被引量:1
  • 10杨宁,王恬,惠起源.PI3K-Akt信号通路与胃癌的研究进展[J].现代肿瘤医学,2010,18(1):197-200. 被引量:16

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部